These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Lee L; Campbell R; Scheuermann-Freestone M; Taylor R; Gunaruwan P; Williams L; Ashrafian H; Horowitz J; Fraser AG; Clarke K; Frenneaux M Circulation; 2005 Nov; 112(21):3280-8. PubMed ID: 16301359 [TBL] [Abstract][Full Text] [Related]
8. Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease. Killalea SM; Krum H Am J Cardiovasc Drugs; 2001; 1(3):193-204. PubMed ID: 14728034 [TBL] [Abstract][Full Text] [Related]
9. Effects of perhexiline-induced fuel switch on the cardiac proteome and metabolome. Yin X; Dwyer J; Langley SR; Mayr U; Xing Q; Drozdov I; Nabeebaccus A; Shah AM; Madhu B; Griffiths J; Edwards LM; Mayr M J Mol Cell Cardiol; 2013 Feb; 55():27-30. PubMed ID: 23277191 [TBL] [Abstract][Full Text] [Related]
10. Metabolic therapeutics in angina pectoris: history revisited with perhexiline. Inglis S; Stewart S Eur J Cardiovasc Nurs; 2006 Jun; 5(2):175-84. PubMed ID: 16469541 [TBL] [Abstract][Full Text] [Related]
11. Pleiotropic mechanisms of action of perhexiline in heart failure. George CH; Mitchell AN; Preece R; Bannister ML; Yousef Z Expert Opin Ther Pat; 2016 Sep; 26(9):1049-59. PubMed ID: 27455171 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Wang Y; Lu JH; Wang F; Wang YN; He MM; Wu QN; Lu YX; Yu HE; Chen ZH; Zhao Q; Liu J; Chen YX; Wang DS; Sheng H; Liu ZX; Zeng ZL; Xu RH; Ju HQ Cancer Lett; 2020 Mar; 473():74-89. PubMed ID: 31904482 [TBL] [Abstract][Full Text] [Related]
13. Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit. Phuong H; Choi BY; Chong CR; Raman B; Horowitz JD Ther Drug Monit; 2016 Feb; 38(1):73-8. PubMed ID: 26309031 [TBL] [Abstract][Full Text] [Related]
14. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation. Horowitz JD; Chirkov YY Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436 [No Abstract] [Full Text] [Related]
15. Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium. Unger SA; Kennedy JA; McFadden-Lewis K; Minerds K; Murphy GA; Horowitz JD J Cardiovasc Pharmacol; 2005 Dec; 46(6):849-55. PubMed ID: 16306812 [TBL] [Abstract][Full Text] [Related]
16. Interaction of terbinafine (anti-fungal agent) with perhexiline: a case report. Sheikh AR; Westley I; Sallustio B; Horowitz JD; Beltrame JF Heart Lung Circ; 2014 Jun; 23(6):e149-51. PubMed ID: 24373912 [TBL] [Abstract][Full Text] [Related]
17. The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Dhakal B; Li CMY; Li R; Yeo K; Wright JA; Gieniec KA; Vrbanac L; Sammour T; Lawrence M; Thomas M; Lewis M; Perry J; Worthley DL; Woods SL; Drew P; Sallustio BC; Smith E; Horowitz JD; Maddern GJ; Licari G; Fenix K Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205791 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent. Cole PL; Beamer AD; McGowan N; Cantillon CO; Benfell K; Kelly RA; Hartley LH; Smith TW; Antman EM Circulation; 1990 Apr; 81(4):1260-70. PubMed ID: 2180591 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial free fatty acid β-oxidation supports oxidative phosphorylation and proliferation in cancer cells. Rodríguez-Enríquez S; Hernández-Esquivel L; Marín-Hernández A; El Hafidi M; Gallardo-Pérez JC; Hernández-Reséndiz I; Rodríguez-Zavala JS; Pacheco-Velázquez SC; Moreno-Sánchez R Int J Biochem Cell Biol; 2015 Aug; 65():209-21. PubMed ID: 26073129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]